Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug (Q31923170)

5 July 2017

title

Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug (English)

1 reference

5 July 2017

0 references

Erba F

1 reference

5 July 2017

Fiorucci L

1 reference

5 July 2017

Pascarella S

1 reference

5 July 2017

Menegatti E

1 reference

5 July 2017

Ascenzi P

1 reference

5 July 2017

Ascoli F

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

published in

Biochemical Pharmacology

1 reference

5 July 2017

1 reference

5 July 2017

1 reference

5 July 2017

page(s)

271-276

1 reference

The human mast cell tryptase tetramer: a fascinating riddle solved by structure

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Human Mast Cell Tryptase Fibrinogenolysis: Kinetics, Anticoagulation Mechanism, and Cell Adhesion Disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Mast cell tryptase is a mitogen for cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Human beta-tryptase is a ring-like tetramer with active sites facing a central pore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Interactions of human mast cell tryptase with biological protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Gabexate mesylate inhibition of serine proteases: thermodynamic and computer-graphics analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Cross-Enzyme Inhibition by Gabexate Mesylate: Formulation and Reactivity Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Bovine mast cell tryptase inactivation: effect of temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

cDNA cloning and primary structure of tryptase from bovine mast cells, and evidence for the expression of bovine pancreatic trypsin inhibitor mRNA in the same cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Comparative protein modelling by satisfaction of spatial restraints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Structure of alpha-chymotrypsin refined at 1.68 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Recognition of errors in three-dimensional structures of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

PROCHECK: a program to check the stereochemical quality of protein structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Competitive Inhibition of Swine Kidney Copper Amine Oxidase by Drugs: Amiloride, Clonidine, and Gabexate Mesylate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Effect of gabexate mesylate (FOY), a drug for serine proteinase-mediated diseases, on the nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Potent selective nonpeptidic inhibitors of human lung tryptase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-[4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy]-pen tane (AMG-126737).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

A framework for the aetiogenesis of chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

Purification of tryptase from a human mast cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900550-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(00)00550-5

1 reference

5 July 2017

1 reference